Application of CRISPR/cas systems in the rapid diagnosis of Coronavirus disease 2019

In recent years, emerging molecular diagnostic tools based on clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) systems have opened up new opportunities for pathogen diagnosis. This article will focus on the potential capabilities of the existing and under-research CRISPR/Cas systems for rapid diagnosis of the coronavirus disease 2019 (COVID-19), and discuss their clinical applications and challenges.